Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

Fig. 1

Characterization of nanoparticles. (A) SEM images: HMSNs. Scale bar, 300 nm. (B) TEM images: HMSNs particles. Scale bar, 200 nm. (C) The surface element (C, O, Si) mapping of HMSNs. (D) HMSNs particles size distribution by intensity. (E) Zeta potential of HMSNs (-NH2), PLTM and PLTM-HMSNs (mean ± SD; n = 3). (F, G) TEM images: PLTM, Scale bar, 200 nm; PLTM-HMSNs, Scale bar, 100 nm. (H) Membrane proteins detected by western blot. (H, I) CD41 and P-selectin during the construction of PLTM-HMSNs, PLTM as a control (mean ± SD). (J) Confocal laser photo of aPD-1-PLTM-HMSNs@Sora (CY5.5 (red) stained aPD-1, FITC (green) labeled HMSNs)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us